Valcyte (Valganciclovir): Clinical Overview for Pharmacists
1. Introduction Valcyte® (valganciclovir) is a prodrug of ganciclovir, primarily indicated for the prophylaxis and treatment of cytomegalovirus (CMV) infections in immunocompromised patients, particularly those with acquired immunodeficiency syndrome (AIDS) or following solid organ transplantation. CMV remains a significant cause of morbidity and mortality in these populations due to its ability to cause severe systemic…